We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGLS
6501
DELISTED
Regulus Therapeutics
RGLS
$0 ﹤0.01%
73
+63
+630% +$412
RNRG icon
6502
Global X Renewable Energy Producers ETF
RNRG
$26M
-199
Closed -$7K
RSF
6503
RiverNorth Capital and Income Fund
RSF
$58.8M
-200
Closed -$3K
OLOX
6504
Olenox Industries
OLOX
$6.68M
0
SGLY icon
6505
Singularity Future Technology
SGLY
$4.13M
0
SGRP
6506
DELISTED
SPAR Group
SGRP
-3
Closed
SMN icon
6507
ProShares UltraShort Materials
SMN
$3.97M
-10
Closed -$3K
SNES icon
6508
SenesTech
SNES
$7M
0
SSKN
6509
DELISTED
Strata Skin Sciences
SSKN
-2
Closed
STKS icon
6510
The ONE Group
STKS
$56.5M
-1,187
Closed -$2K
STRM
6511
DELISTED
Streamline Health Solutions
STRM
$0 ﹤0.01%
7
STRT icon
6512
STRATTEC Security
STRT
$369M
$0 ﹤0.01%
17
-40
-70% -$611
TAIT
6513
DELISTED
Taitron Components
TAIT
-25
Closed
TENX icon
6514
Tenax Therapeutics
TENX
$401M
0
TNXP icon
6515
Tonix Pharmaceuticals
TNXP
$161M
0
TOVX icon
6516
Theriva Biologics
TOVX
$9.64M
$0 ﹤0.01%
1
-1
-50% -$95
TTNP
6517
DELISTED
Titan Pharmaceuticals
TTNP
$0 ﹤0.01%
1
URTY icon
6518
ProShares UltraPro Russell2000
URTY
$327M
-344
Closed -$7K
USAU icon
6519
US Gold Corp
USAU
$223M
$0 ﹤0.01%
70
+2
+3% +$12
UWM icon
6520
ProShares Ultra Russell2000
UWM
$247M
-3,626
Closed -$60K
VGZ icon
6521
Vista Gold
VGZ
$260M
$0 ﹤0.01%
200
-76,500
-100% -$60.1K
VIRC icon
6522
Virco
VIRC
$94.4M
$0 ﹤0.01%
1
VTSI icon
6523
VirTra
VTSI
$35.7M
-3
Closed
VUSE icon
6524
Vident US Equity Strategy ETF
VUSE
$672M
-1,491
Closed -$34K
WHLR
6525
Wheeler Real Estate Investment Trust
WHLR
$641K
0

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.